Résumé
Background: In ophthalmology (OPD), cycloplegics or mydriatics were needed for doing correct refraction and evaluation of fundus on a daily basis. Aims and Objectives: The objectives of this study were to compare the clinical efficacy and systemic side effects of different dilutions of phenylephrine and tropicamide combinations drops on pupil dilatation and to measure and compare pulse rate and blood pressure before and after giving the drug. Materials and Methods: The present study is a hospital-based interventional study conducted among patients attending to OPD of Regional Eye hospital, Visakhapatnam during April 2012–August 2012. Eighty-one patients randomly allocated to two groups (41 patients in Group 1 and 40 patients in Group 2). Dilution of phenylephrine 5% and Tropicamide 0.8% mixture was applied to patients of Group A in both eyes and dilution of phenylephrine 2.5% and Tropicamide 0.4% mixture was applied to Group B patients in both eyes. Pupil diameter and pulse rate BP were measured and compared. Results: Mean age of Group 1 patients was 55.39 ± 11.47 and Group 2 was 49.95 ± 13.71. Among 36 males, 50% in Group 1 and 50% in Group 2 and among 45 females 51.1% in Group 1 and 48.9% in Group 2. Among both Group 1 and Group 2 patients, both left and right pupil size was significantly increased after application of dilutions, but there was more increase in the pupil size among Group 1 patients compared to Group 2 patients 15 min after and 30 min after application of drug. Conclusions: The combination of 0.8% tropicamide and 5% phenylephrine was effective compared to alternate application of 0.4% tropicamide and 2.5% phenylephrine for rapid and sustainable pupil dilatation for indirect ophthalmoscopy.
Résumé
Purpose: The study was conducted to evaluate efficacy of intracameral lidocaine hydrochloride 1% and tropicamide injection 0.02% for anaesthesia and mydriasis in manual small?incision cataract surgery (MSICS) and to report any adverse drug reaction. Methods: This was a randomized, prospective, observational study on 32 participants that took place from October 2021 to March 2022 (6 months). Patients between age group 40� year with nuclear sclerosis cataract and pupil diameter >6 mm in preoperative evaluation were included in the study. Patients with pseudoexfoliation, rigid pupil, senile miosis, history of uveitis, ocular trauma, recent ocular infections, with known allergy to tropicamide, all types of glaucoma were excluded from the study. Results: Thirty?two eyes with nuclear sclerosis cataract who underwent MSICS were studied. Fixed dose combination of 2 ml phenyl epinephrine (0.31%), tropicamide (0.02%), and lidocaine (1%) intracamerally was used for mydriasis and analgesia. More than 7 mm pupillary dilatation was achieved within 20 seconds of injection in 29 cases (90.6%). Mild pain and discomfort was noted in 12 cases (37.5%). Postoperative day 1 unaided visual acuity was in the range of 6/18�12 for all patients and grade 1 iritis was seen in 7 cases (21.8%) which was self?limiting. No adverse event like corneal decompensation or TASS were noted.Conclusion: Thus, Intracameral injection of mydriatic provides rapid and sustainable mydriasis and analgesia for manual SICS
Résumé
Over the past 15 years, the increasing nonmedical use of tropicamide ophthalmic drops has been reported in Europe, coinciding with an increase in opioid addiction and drug-related mortality. Although tropicamide is generally known as a cheap alternative to heroin in Eastern Europe, it still appears to be a relatively new phenomenon that has arisen over the last decade. A narrative review was conducted of all the relevant sources published in more than five countries between January 1, 1975 and January 10, 2021. For bibliographic accuracy, the materials published in Russian and Italian were professionally translated to English. During the preparation of this report, we were able to interview five Russian-speaking patients who injected tropicamide in the past and we discuss another case of intravenous tropicamide use. This review was acknowledged by the institutional review board of the University of Missouri-Kansas City. All patients interviewed at the Unica Medical Center consented for their clinical information to be reported in a medical publication. We analyzed data from 50+ various sources and covered a variety of drug-related issues, including information on the extent, patterns, and trends in tropicamide use, its health consequences, and other clinical findings. The information provided in this article may help providers better detect tropicamide abuse and incorporate new rehabilitation strategies into the management of these patients.
Résumé
ABSTRACT Purpose: To evaluate the effect of pupil dilation on intraocular pressure in preterm and term newborns. Methods: This prospective study involved 55 eyes of 28 preterm infants and 38 eyes of 20 term infants. The infants were divided into two groups according to their gestational ages at birth as follows: preterm group, <37 weeks and term group, ≥37 weeks. Pupil dilation was attained with tropicamide 0.5% and phenylephrine 2.5%. Intraocular pressure measurements were performed with Icare PRO (Icare Finland Oy, Helsinki, Finland) before and after pupil dilation. A paired t test was used to compare the measurements before and after pupil dilation. Results: The mean intraocular pressure change was -1.04 ± 3.03 mmHg (6.20/-11.40 mmHg) in the preterm group and -0.39 ± 2.81 mmHg (4.60/-9.70 mmHg) in the term group. A statistically significant difference in intraocular pressure was observed only in the preterm group after pupil dilation (p=0.01). Conclusion: An unexpected alteration in intraocular pressure in newborns may occur after pupil dilation, especially in preterm infants.
RESUMO Objetivo: Avaliar o efeito da dilatação da pupila sobre a pressão intraocular em recém-nascidos pré-termo e a termo. Métodos: Este estudo prospectivo envolveu 55 olhos de 28 bebês pré-termo e 38 olhos de 20 bebês a termo. Os bebês foram divididos em dois grupos, pré-termo e a termo, de acordo com a idade gestacional ao nascimento: grupo pré-termo <37 semanas; grupo a termo ≥37 semanas. A dilatação da pupila foi feita com tropicamida 0,5% e fenilefrina 2,5%. As medições da pressão intraocular foram realizadas com Icare PRO (Icare Finland Oy, Helsinki, Finlândia) antes e depois da dilatação da pupila. O teste t pareado foi usado para comparar as medidas antes e depois da dilatação da pupila. Resultados: A alteração média da pressão intraocular foi de -1,04 ± 3,03 mmHg (+6,20/-11,40 mmHg) no grupo pré-termo e -0,39 ± 2,81 mmHg (+4,60/-9,70 mmHg) no grupo a termo. Uma diferença estatisticamente significativa na pressão intraocular foi observada apenas no grupo pré-termo após a dilatação da pupila (p=0,01). Conclusão: Após a dilatação da pupila, pode ocorrer alteração inesperada da pressão intraocular em recém-nascidos, principalmente em bebês pré-termo.
Résumé
AIM:To evaluate the curative effect of Chinese medicine physiotherapy combined with tropicamide eye drops to treat pseudomyopia in children and adolescent. METHODS: We collected randomized controlled trials from CNKI, CBM, Wanfang database, PubMed, EMBASE and Cochrane Library in 2000-2015, and the improved Jadad scale was used to evaluate the methodology of the literature, and the data was extracted. The Review Manager 5. 3 statistical software was used for meta analysis. RESULTS: A total of 5 articles were included in the analysis, with a total sample size of 836 cases. The curative effect of experimental group on pseudomyopia was better than that of control group,and the differences are statistically significant (Z=6.39,P<0.01). CONCLUSION: Compared with topiramine eye drops alone, combined with traditional Chinese medicine therapy for treating pseudomyopia in children and adolescent is more effective,and is safe and reliable.
Résumé
The objective of this work was to investigate the efficacy and safety of natural oils (castor oil and olive oil) based phase transition microemulsion systems for ocular delivery with reference to ethyl oleate systems. Tropicamide was used as model drug and was incorporated in the formulation at a concentration of 0.5% w/w. The phase transition systems comprised the oil, surfactant and water with the phase behavior depending on the concentration of water. The tested systems included microemulsion (ME), liquid crystalline system (LC) and coarse emulsion (EM). The efficacy of these systems was evaluated by monitoring the mydriatic response in comparison to drug solution containing polyvinylpyrrolidone (PVP). Ocular irritation was monitored by visual inspection and tear flow estimation. Drug release depended on the formulation type and viscosity. Thus LC systems produced the slowest release rates followed by the ME with the EM producing the largest release rate. The mydriatic response versus time plots showed biphasic effect with two maxima (MRmax) which verified the systemic absorption of the drug. Both ethyl oleate and olive oil based systems were more effective than the control with respect to the area under the mydriatic response profile. However, castor oil based systems were comparable to the control. With respect to ocular irritation castor oil based system were the least irritant followed by olive oil systems with ethyl oleate systems being the most irritant. The study thus introduced olive oil based phase transition systems for ocular drug delivery with lower irritation compared to the synthetic oil systems.
Résumé
Background: Dilating the pupil is one of the most commonly practiced methods among ophthalmologists to examine the eye especially the posterior segment of the eye. Here we conducted a study to know the clinical effect of proparacaine, a local anesthetic, on tropicamide-induced pupillary dilation. Methods: A Quasi-experimental study was conducted on 57 subjects aged between 20 and 70 years. Study was done over a period of 3 months (February 14 - April 14) at a tertiary health care center in Bagalkot after obtaining institutional ethical committee clearance. Proparacaine was instilled in one eye (right eye) before instilling tropicamide and the other eye with a placebo (normal saline). Pupil diameter was measured using a pupillary gauge at 0, 15, and 30 mins. Results were analyzed using unpaired Student’s t-test. Results: The mean clinically efficient pupillary diameter at the end of 15 mins in proparacaine instilled eye was 5.56±0.5 and in control eye was 5.25±0.45 mm with t value 8.13 (p<0.001) which was statistically significant. And at the end of 30 mins pupillary diameter in the study group was 7.96±0.43 mm and in the control group was 7.83±0.43 mm with t value of 4.115 (p<0.001) which was also statistically significant. Conclusions: Therefore, we do recommend the use of proparacaine before instilling tropicamide for faster pupillary dilation.
Résumé
Objective To explore the effect of compound Tropicamide eye drop in pseudomyopia preventive treatment and summerize key points of nursing.Methods Sixty-six cases of juveniles with pseudomyopia were selected from patients in the Department of Ophthalmology, which were randomly divided into the experiment group(n=33)and control group(n=33). The control group used Atropine eye drop for treatment every night while the experiment group used compound Tropicamide. Both of Treatment durations were 30 days and the effects of the two groups after 10~30d were compared.Result The curative effect in the experiment group was significantly better than that of the control group(P<0.01)with statistically difference.Conclusions Effect of compound Tropicamide eye drop in treatment of juvenile pseudomyopia is better than that of Atropine eye drop. Recommendations and notes about the prevention and treatment of juvenile pseudomyopia should be provided for education.
Résumé
AlM: To investigated the refraction and cycloplegic effects of 0. 5g/L tropicamide eye drops in various low myopia age groups, and provide clinical guidelines for proper usage of cyclopegic agent in different population.METHODS:Three low myopia age groups (n=45) were selected, non-cycloplegic and cycloplegic auto-refraction using “Shin-Nippon” auto-refractor were performed at various time point for refractive error. The subjective accommodation amplitudes were also collected at each time point. RESULTS: The accommodation amplitude showed a similar but significant decline between 20~60min after the first cyclopegic drops in all three age groups. However, the decline of accommodation amplitudes were not statistically correlated with the results of “Shin-Nippon”auto-refraction results at different time points. CONCLUSlON: The refraction time should be arranged according to the cycloplegic effects of tropicamide. Open-field auto-refractor could reduce the usage of cycloglegice drugs in low myopia groups, even for the youngest.
Résumé
Objective To investigate the effects of tropicamide and esculin-digitalisglycosides combination eye drops on low myopia of children (age ranging from 6 to 14). Methods Eighty children with 160 eyes of low myopia in the outpatient department of ophthalmology of our hospital were chose from July 2010 to April 2013, then the patients were equally divided into four groups:the control, esculin-digitalisglycosides eye drops,tropicamide,and tropicamide and esculin-digitalisglycosides combination groups. The naked vision and myopia correction of each group were compared before and after treatment for two weeks, and the treatment effects were compared among four groups. Results (1) The results showed there were no significant changes before and after treatment in the control, esculin-digitalisglycosides eye drops and tropicamide groups ( >0.05); (2) On the contrast, the tropicamide and esculin-digitalisglycosides combination have significantly improved naked vision and myopia correction after 2 weeks ( <0.05);(3) Prior to the treatment,there was no significant difference among four groups (<0.05);(4) After treatment,group under tropicamide and esculin- digitalisglycosides combined was statistical different from the other groups treated with other three eye drops ( <0.05);However, there was no statistical difference among groups in these three eyedrops. Conclusion Esculin-digitalisglycosides combined with tropicamide was the most effective treatment for low myopia of children.
Résumé
ObjectiveTo investigate the effect of tropicamide eyedrop in the treatment adolescent pseudomyopia.Methods Tropicamide eyedrop were instilled at 68 adolescents( 136 eyes) with pseudomyopia.Effects of mydriasis were observed and visual acuity scopes were analyzed based on chi-square test.ResultsThe time interval( 1 minute or five minutes time interval) between the instillation of the two drops had no significant influence on effects of mydriasis(P ＞0.05 ).And the time interval between the instillation of the two drops had no significant influence on dioptoscopy(P ＞ 0.05 ).There was significant difference in the visual acuity scopes before treatment and post-treatment( x2=16.3308,P=0.000969964).There was significant difference in the visual acuity scopes in one-week treatment and four-week treatment ( x2 =50.2750,P =6.98115 × 10-11 ).Conclusion Instilling two drops of 0.25％tropicamide eyedrop 1 minute or 5 minutes could achieve satisfied mydriasis effect.Short-term application of tropicamide eyedrop could relieve the spasm of adolescent pseudomyopia.
Résumé
Se desarrolló y validó un método analítico por cromatografía líquida de alta resolución, aplicable al control de la calidad y el estudio de estabilidad de fenilefrina 10 por ciento más tropicamida 1 percent, colirio. Para cuantificar simultáneamente los 2 principios activos en el producto terminado, la separación se realizó a través de una columna cromatográfica Lichrosorb RP-18 (5 µm) (250 x 4 mm), con detección ultravioleta a 253 nm, empleando una fase móvil compuesta por metanol:agua destilada (1:1), con 1,1 g de 1-octanosulfonato de sodio por litro ajustado pH a 3,0 con ácido fosfórico y la cuantificación de este frente a una muestra de referencia con el método del estándar externo. El método analítico desarrollado resultó lineal, preciso, específico y exacto en el rango de concentraciones estudiadas, el cual se estableció para el control de la calidad y el estudio de estabilidad del producto terminado ya que no existían métodos analíticos reportados para estos fines
An analytical high-performance liquid chromatography method was developed and validated applicable to quality control and to stability study of 10 percent phenylephrine plus eyedrops 1 percent tropicamide. To quantify simultaneously both active principles in the finished product, separation was carried out through a Lichrosorb RP-18 (15 µm) (260 x 4 mm) column chromatography, with ultraviolet detection at 253 nm using the mobile phase composed of methanol: distilled water (1:1), with 1.1 g of sodium 1-octasulfanate by litre and pH fitted to 3,0 with phosphoric acid and the quantification of this front to a reference sample using the external standard method. The analytical method developed was linear, precise, specific and accurate in the rank of study concentrations, established for the quality control and stability study of the finished product since there were not analytical methods designed for these aims
Sujets)
Préparations pharmaceutiques , Contrôle de qualitéRésumé
PURPOSE: To investigate the effects of pupil dilation and constriction agents on the survival and production of nitric oxide (NO) in cultured human trabecular meshwork cells (HTMC). METHODS: Primarily cultured HTMC were exposed to 0, 0.01, and 0.1 mg/ml of tropicamide, cyclopentolate, atropine, or pilocarpine for 2 hours. Cellular survival and production of NO were assessed using the MTT assay and Griess assay, respectively. RESULTS: Tropicamide, cyclopentolate, atropine, and pilocarpine decreased cellular survival at the concentration of 0.1 mg. At the concentration of 0.01 mg/ml, all agents decreased production of NO to some extent, although the reduction was not statistically significant. CONCLUSIONS: Pupil dilation and constriction agents may be toxic to HTMC if used at high concentrations or if used frequently in the short-term but may not affect trabecular outflow.
Sujets)
Humains , Atropine , Constriction , Cyclopentolate , Monoxyde d'azote , Pilocarpine , Pupille , Réseau trabéculaire de la sclère , TropicamideRésumé
El colirio de fenilefrina 10 por ciento y tropicamida 1 por ciento se emplea en la pràctica médica como antihistamínico, analgésico, midriàticos y ciclopléjicos. El objetivo del presente trabajo consistió en desarrollar una formulación de fenilefrina 10 por ciento y tropicamida 1 por ciento que cumpliera con las especificaciones de calidad establecidas por el fabricante, que fuera estable física, química y microbiológicamente, para lo cual se realizó un diseño y los estudios de preformulación. Se estudió ademàs, las especificaciones de calidad de la formulación seleccionada, la estabilidad del producto y el tiempo de vigencia de este. Se desarrolló y validó un método analítico para el control de la calidad y el estudio de estabilidad del producto terminado por cromatografía líquida de alta resolución. Se realizaron los resultados analíticos del estudio de estabilidad acelerado y por vida de estante, para lo cual se emplearon 3 lotes del producto a escala piloto. El colirio resultó estable física, química y microbiológicamente envasado en frascos de polietileno de baja densidad, por un tiempo de 12 meses almacenados a temperatura ambiente.
The 10 percent Phenylephrine and 1 percent Tropicamide eyedrops is used in medical practice as antihistaminic, analgesic, mydiatric and cycloplegic. The aim of present paper was to develop a 10 percent Phenylephrine and 1 percent Tropicamide formula fulfilling the quality specifications established by manufacturer physically, chemically and microbiologically stable with the performing of a design and pre-formula studies. Also, we studied the quality specifications of selected formula, the product stability and its expiry time. An analytical method was developed and validated to quality control and stability study of the finished product by high-performance liquid chromatography. Analytical results of accelerated stability study and by shelf life using 3 batches of product at pilot scale. Eyedrops was physically, chemically and microbiologically stable when it was bottling in low density polyethylene flasks during 12 months of storage at room temperature.
Sujets)
Stabilité de médicament , Phényléphrine/normes , Amélioration de la qualité , Tropicamide/normesRésumé
Acute psychosis and confusional states are known complications of treatment with anticholinergic agents in the elderly. We report an 87-year-old female patient presenting with acute neurobehavioral abnormalities requiring hospitalization immediately after starting treatment for openangle glaucoma with the topic cycloplegic muscarinic receptor blocker tropicamide. Case-effect relationship was confirmed. The authors make a review of the literature trying to identify the clinical manifestations and risk factors for this complication.
Tratamento com drogas anticolinérgicas é uma causa conhecida de alterações agudas do estado mental em idosos. Relata-se o caso de uma paciente de 87 anos de idade com alterações comportamentais agudas, que necessita de internamento imediatamente após início de terapia para glaucoma de ângulo aberto com tropicamida, um agente cicloplégico bloqueador de receptor muscarínico. A relação causa-efeito foi confirmada depois de a droga ter sido reiniciada durante o internamento. É apresentada uma revisão da literatura delineando as manifestações clínicas mais comuns e fatores de risco para essa complicação.
Sujets)
Humains , Femelle , Sujet âgé de 80 ans ou plus , Antagonistes cholinergiques/usage thérapeutique , Glaucome à angle ouvert/traitement médicamenteux , Hallucinations , Troubles psychotiques/diagnostic , Tropicamide/administration et posologie , Tropicamide/effets indésirables , BrésilRésumé
Purpose: To compare the efficacy in pupil dilatation between a mixture containing 0.75% tropicamide and 2.5% phenylephrine and the alternate application of 1% tropicamide and 10% phenylephrine eye drops. Material and Methods: Patients requiring pupil dilatation were randomized to receive one drop of the mixture every 10 min for four times or our standard application of one drop of 1% tropicamide alternating with one drop of 10% phenylephrine every 10 min for two cycles. Pupil size was measured under bright light with the pupil gauge before, and every 5 min after initial application for 40 min. Application of the drops was discontinued once the pupil diameter reached 7 mm. Blood pressure and pulse rate were monitored every 15 min. Results: Of 40 patients (age 57.3±10.9 years, range 35-70 years), 22 were randomized into the mixture group and 18 into the alternate drug group. Baseline pupil sizes were 1.7±0.5 mm in the mixture group and 1.8±0.4 mm in the alternate drug group. The pupils were successfully dilated to 7 mm within 40 min in 17 patients of the mixture group compared to seven patients in the alternate drug group (P=0.004, Log Rank test). The mean pupil sizes at 40 min were 6.6±0.8 and 6.0±0.9 mm in the mixture and alternate drug groups respectively (P=0.050, t-test). Blood pressure and pulse rate were stable and similar in both groups. Conclusions: The mixture of 0.75% tropicamide and 2.5% phenylephrine is superior to our standard application of 1% tropicamide alternating with 10% phenylephrine. It provides faster and more successful pupil dilatation within 40 min.
Sujets)
Adulte , Sujet âgé , Relation dose-effet des médicaments , Méthode en double aveugle , Association médicamenteuse , Femelle , Humains , Mâle , Adulte d'âge moyen , Mydriatiques/administration et posologie , Solutions ophtalmiques , Ophtalmoscopie/méthodes , Phényléphrine/administration et posologie , Pupille/effets des médicaments et des substances chimiques , Reproductibilité des résultats , Tropicamide/administration et posologieRésumé
PURPOSE: To maximize effective use of mydriatic drugs through comparing the pupillary dilation effects between 1% tropicamide and 2.5% phenylephrine. METHODS: Fifty people requiring pupillary dilation were divided into 3 groups. Group 1 was treated with one drop of 1% tropicamide in the right eye and one drop of 2.5% phenylephrine in the left eye. Group 2 was treated twice during a 5-minute interval with 1% tropicamide in the right eye. Group 3 was treated twice during a 5-minute interval with 2.5% phenylephrine in the right eye. Groups 2 and 3 were treated with 2.5% phenylephrine and 1% tropicamide in the left eye, administered during a 5-minute interval. The pupillary size was measured in all groups for 40 minutes following eye drops administration. RESULTS: The mean patient age was 15.7 years. Group 1 included 10 patients, and groups 2 and 3 included 20 patients each. Eight patients in group 1 and 16 patients in group 2 developed a larger right pupil. Fourteen patients in group 3 developed a larger left pupil. CONCLUSIONS: Our study showed that 1% tropicamide, with its parasympathetic antagonistic mechanism of action, was more effective at inducing pupillary dilation than 2.5% phenylephrine, and the combination of 1% tropicamide and 2.5% phenylephrine was more effective than multiple drops of single eye drops.
Sujets)
Adolescent , Adulte , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Jeune adulte , Relation dose-effet des médicaments , Calendrier d'administration des médicaments , Études de suivi , Antagonistes muscariniques/administration et posologie , Mydriatiques/administration et posologie , Solutions ophtalmiques , Phényléphrine/administration et posologie , Pupille/effets des médicaments et des substances chimiques , Troubles de la réfraction oculaire/diagnostic , Études rétrospectives , Tropicamide/administration et posologieRésumé
@#Objective To investigate the changes of central corneal thickness (CCT) caused by mydriasis with Mydrin-P.MethodsA total of 151 patients (302 eyes) with refractive errors were studied. Each eye had instillation of Mydrin-P to obtain mydriasis. CCT was examined before and after mydriasis by ultrasonic pachymeter. Changes of CCT were observed.ResultsCCT was 549.40±25.47 μm before mydriasis and 562.14±25.84 μm after mydriasis with a significant different between two examinations( P<0.001). ConclusionMydriasis with Mydrin-P can affect the measurement of CCT.
Résumé
Objective To study the influence of different eyedroping interval on the effects of mydriasis.Methods Divided the selected patients into the experiment group(126 cases) and the control group(128 cases) randomly.Different eyedroping interval were adopted in the different group,and then compared the datum which obtained from 2 groups.Results The diameter of pupils in the experiment group were 7.45 mm and the 7.48 mm respectively after the mydriasis,which in the control group were 6.96 mm and 7.00 mm respectively,the difference between the 2 groups was significant.Conclusion Using eyedrop of tropicamide by every 5 minutes can effective shorten the operation time and can obtain better effects than the routine method.
Résumé
Objective To analyze the effect of intensive pupillary dilation on intraocular pressure(IOP) in early stage after vitreoretinal surgery(VRS).Design Retrospective case series.Participants 32 patients(34 eyes) with 30 mmHg or more of IOP at the first day after VRS were enrolled in this study.Methods Tropicamide-phenylephrine eyedrop(Mydrin-P~(?)) was applied to the operated eye 3 times with interval of 5 minutes and IOP was measured again 2 hours later.IOPs were compared with t test.Main Outcome Measures IOP.Results The mean IOP was 37.26?6.07 mmHg before using tropicamide-phenylephrine eyedrop and 34.82?8.46 mmHg after using it two hours later(P=0.02),and mean decline of IOP was 2.44 mmHg in general.IOP was decreased in 20/34 eyes(58.82%) with mean decline 6.2 mmHg.IOP was unchanged in 4/34 eyes(11.76%).IOP was increased in 10/34 eyes(29.41%) with mean IOP up 4.1 mmHg.Conclusions The IOP increasing after vitreoretinal surgery is not the reason for stopping pupillary dilator.On the contrary,the IOP of about 60%patients can decrease with rational using pupillary dilator.